Abstract:Objective: The vital pathogenesis of varicose veins includes remodeling of the extracellular matrix and decreased vascular tone. Prostaglandin E-2 (PGE(2)), a small molecule substance and inflammatory medium that belongs to the arachidonic acid derivatives, has the capacity to influence the expression of metalloproteinase and the vascular tone of the venous wall. The purpose of the present study was to investigate the role of PGE(2) in the development of varicose veins in lower limbs. Methods: The collected venous specimens were analyzed using hematoxylin and eosin, Masson's trichrome, and immunohistochemical staining. Transforming growth factor (TGF)-beta 1, PGE(2), CD31, and alpha-smooth muscle actin antibody were used to detect the expression and distribution of these proteins. The effect of PGE(2) on the proliferation, migration, and tube formation capacity of human umbilical vein endothelial cells (HUVECs) was detected in vitro. The effect of TGF-beta 1 on the expression of PGE(2) and matrix metalloproteinases (MMPs) was assessed using Western blotting. Quantitative reverse transcription polymerase chain reaction was used to evaluate the effect of PGE(2) on the expression of nitric oxide synthase (NOS) and other genes. Results: The expression of PGE(2) and TGF-beta 1 in varicose veins was upregulated in the media tunica and intima tunica, and a strong positive correlation was found between PGE(2) and TGF-beta 1 expression in both varicose veins (95% confidence interval, 0.5207-0.9582; R = 0.848; P = .0005) and normal veins (95% confidence interval, 0.2530-0.8532; R = 0.643; P = .003). PGE(2) promoted the migration and tube formation ability of HUVECs. Moreover, PGE(2) also upregulated the expression of MMP-1 and TGF-beta 1 in HUVECs and increased the mRNA level of inducible NOS. Conclusions: PGE(2) can affect the remodeling of the extracellular matrix and reduce the elasticity of the vascular walls by promoting the synthesis of TGF-beta 1 and MMP-1. PGE(2) can also reduce the tension of the great saphenous vein by promoting the expression of inducible NOS, thus aggravating the blood stasis. Clinical Relevance: Lower limb varicose veins are characterized by remodeling of the extracellular matrix and a lower vascular tone, which contribute to the reflux of venous blood and the higher pressure in the vascular wall. In the present study, prostaglandin E-2 was shown to contribute to the progression of lower limb varicose veins. Prostaglandin E-2 not only affected the remodeling of the extracellular matrix but also reduced the wall tension of the great saphenous veins by promoting the expression of inducible nitric oxide synthase, thus aggravating blood stasis. These two mechanisms might explain why tortuous and dilated varicose veins appear gradually.

Prostaglandin E2 stimulates the production of vascular endothelial growth factor through the E-prostanoid-2 receptor in cultured human lung fibroblasts.

Phosphodiesterase-4 inhibition augments human lung fibroblast vascular endothelial growth factor production induced by prostaglandin E2.

Prostacyclin Analogs Stimulate Vegf Production from Human Lung Fibroblasts in Culture

Prostaglandin E₂ inhibits human lung fibroblast chemotaxis through disparate actions on different E-prostanoid receptors.

Prostaglandin E_2 Inhibits Transforming Growth Factor-Β_1 Triggered Lung Fibroblast-Myofibroblast Transdifferentiation and Collagen I Production in Vitro

Prostaglandin E(2) Mediates Il-1 Beta-Related Fibroblast Mitogenic Effects In Acute Lung Injury Through Differential Utilization Of Prostanoid Receptors

Targeted Disruption of the Prostaglandin E2 E-prostanoid 2 Receptor Exacerbates Vascular Neointimal Formation in Mice.

Attenuation of inhibitory prostaglandin E2 signaling in human lung fibroblasts is mediated by phosphodiesterase 4.

Prostaglandin E2 Promotes Endothelial Differentiation from Bone Marrow-Derived Cells Through AMPK Activation

Effects of prostaglandin E2 on expression of vascular endothelial growth factor in human gastric cancer cell line MKN28

Engineered endothelial progenitor cells that overexpress prostacyclin protect vascular cells.

Vitamin D Modulates Prostaglandin E2 Synthesis and Degradation in Human Lung Fibroblasts.

PGE(2) up-regulates vascular endothelial growth factor expression in MKN28 gastric cancer cells via epidermal growth factor receptor signaling system

Prostaglandin E(2) protects human lung fibroblasts from cigarette smoke extract-induced apoptosis via EP(2) receptor activation.

Prostaglandin E2 Induces Stromal Cell-Derived Factor-1 Expression in Prostate Stromal Cells by Activating Protein Kinase A and Transcription Factor Sp1.

Cooperative effects of FGF-2 and VEGF-A in periodontal ligament cells

Prostaglandin D-2 Inhibits Fibroblast Migration

Prostaglandin-E2 Contracts Vascular Smooth-Muscle and Inhibits Potassium Currents in Vascular Smooth-Muscle Cells of Rat Tail Artery

Transforming Growth Factor-Β1 and Inducible Nitric Oxide Synthase Signaling Were Involved in Effects of Prostaglandin E2 on Progression of Lower Limb Varicose Veins

Roles of Cyclooxygenase-2 in Microvascular Endothelial Cell Proliferation Induced by Basic Fibroblast Growth Factor.

[Mechanisms of Prostaglandin E2-induced Bone Marrow-Derived Progenitor Cell Differentiation].